DETERMINATION OF ANTICARDIOLIPIN AND OTHER ANTIBODIES IN HIV-1-INFECTED PATIENTS

被引：0
|
作者：
BERNARD, C
EXQUIS, B
REBER, G
DEMOERLOOSE, P
机构：
[1] UNIV GENEVA, HOP CANTONAL, HEMOSTASIS UNIT, CH-1211 GENEVA 4, SWITZERLAND
[2] UNIV GENEVA, HOP CANTONAL, DEPT MED, DIV HEMATOL, CH-1211 GENEVA 4, SWITZERLAND
来源：
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1990年 / 3卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：536 / 539
页数：4
相关论文
共 50 条
  • [41] INCIDENCE OF ANTICARDIOLIPIN ANTIBODIES IN HEMOPHILIAC AND NON HEMOPHILIAC PATIENTS WITH HIV-1 ANTIBODIES
    BERNARD, C
    BOSSER, C
    EXQUIS, B
    TREMBLET, C
    REBER, G
    DEMOERLOOSE, P
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 376 - 376
  • [42] Detection of HIV-gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers
    Yasuda, S
    Iwasaki, M
    Oka, S
    Naganawa, S
    Nakasone, T
    Honda, M
    Sata, T
    Kojima, A
    Matsuda, S
    Takemori, T
    Tsunetsugu-Yokota, Y
    MICROBIOLOGY AND IMMUNOLOGY, 1998, 42 (04) : 305 - 311
  • [43] Prevalence of antibodies against hepatitis A and B in HIV-1-infected children and adolescents
    Fernandez-Ibieta, Maria
    Tomas Ramos, Jose
    Isabel Gonzalez-Tome, Maria
    Guillen, Sara
    Navarro, Marisa
    Jose Cilleruelo, Maria
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (08): : 449 - 452
  • [44] ANTIBODIES TO THE NEF PROTEIN AND TO NEF PEPTIDES IN HIV-1-INFECTED SERONEGATIVE INDIVIDUALS
    AMEISEN, JC
    GUY, B
    CHAMARET, S
    LOCHE, M
    MOUTON, Y
    NEYRINCK, JL
    KHALIFE, J
    LEPREVOST, C
    BEAUCAIRE, G
    BOUTILLON, C
    GRASMASSE, H
    MANIEZ, M
    KIENY, MP
    LAUSTRIAT, D
    BERTHIER, A
    MACH, B
    MONTAGNIER, L
    LECOCQ, JP
    CAPRON, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (03) : 279 - 291
  • [45] A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects
    Cecilia, D
    Kleeberger, C
    Muñoz, A
    Giorgi, JV
    Zolla-Pazner, S
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (06): : 1365 - 1374
  • [46] INCREASED RECURRENCE OF TUBERCULOSIS IN HIV-1-INFECTED PATIENTS IN KENYA
    HAWKEN, M
    NUNN, P
    GATHUA, S
    BRINDLE, R
    GODFREYFAUSSETT, P
    GITHUI, W
    ODHIAMBO, J
    BATCHELOR, B
    GILKS, C
    MORRIS, J
    MCADAM, K
    LANCET, 1993, 342 (8867): : 332 - 337
  • [47] Impact of lipodystrophy on the quality of life of HIV-1-infected patients
    Blanch, J
    Rousaud, A
    Martínez, E
    De Lazzari, E
    Peri, JM
    Milinkovic, A
    Perez-Cuevas, TB
    Blanco, TL
    Gatell, JM
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (04) : 404 - 407
  • [48] Hyperglycemia associated with protease inhibitors in HIV-1-infected patients
    Gómez-Vera, J
    de Alarcón, A
    Jiménez-Mejías, ME
    Acosta, D
    Prados, D
    Viciana, P
    CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (07) : 391 - 394
  • [49] Associative and predictive biomarkers of dementia in HIV-1-infected patients
    Bandaru, V. V. R.
    McArthur, J. C.
    Sacktor, N.
    Cutler, R. G.
    Knapp, E. L.
    Mattson, M. P.
    Haughey, N. J.
    NEUROLOGY, 2007, 68 (18) : 1481 - 1487
  • [50] Population Pharmacokinetics of Emtricitabine in HIV-1-Infected Adult Patients
    Valade, Elodie
    Treluyer, Jean-Marc
    Bouazza, Naim
    Ghosn, Jade
    Foissac, Frantz
    Benaboud, Sihem
    Fauchet, Floris
    Viard, Jean-Paul
    Urien, Saik
    Hirt, Deborah
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (04) : 2256 - 2261
12345